Kennedy Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$152K Buy
11,674
+544
+5% +$7.08K ﹤0.01% 575
2025
Q1
$118K Buy
11,130
+143
+1% +$1.51K ﹤0.01% 633
2024
Q4
$186K Buy
10,987
+2,036
+23% +$34.6K ﹤0.01% 663
2024
Q3
$208K Buy
+8,951
New +$208K ﹤0.01% 675
2020
Q4
Sell
-74,807
Closed -$3.21M 665
2020
Q3
$3.21M Buy
+74,807
New +$3.21M 0.09% 402